These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15339959)

  • 1. Versipelostatin: unfolding an unsweetened death.
    Sausville EA
    J Natl Cancer Inst; 2004 Sep; 96(17):1266-7. PubMed ID: 15339959
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect on tumor cells of blocking survival response to glucose deprivation.
    Park HR; Tomida A; Sato S; Tsukumo Y; Yun J; Yamori T; Hayakawa Y; Tsuruo T; Shin-ya K
    J Natl Cancer Inst; 2004 Sep; 96(17):1300-10. PubMed ID: 15339968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-damage sensitizers: potential new therapeutical tools to improve chemotherapy.
    Michod D; Widmann C
    Crit Rev Oncol Hematol; 2007 Aug; 63(2):160-71. PubMed ID: 17544289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization of cancer cells to DNA damaging agents by imidazolines.
    Sharma V; Peddibhotla S; Tepe JJ
    J Am Chem Soc; 2006 Jul; 128(28):9137-43. PubMed ID: 16834387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitors, anticancerous mechanism and therapy for gastrointestinal cancers.
    Fang JY
    J Gastroenterol Hepatol; 2005 Jul; 20(7):988-94. PubMed ID: 15955204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.
    Bishton M; Kenealy M; Johnstone R; Rasheed W; Prince HM
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1439-49. PubMed ID: 17944568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of molecular genetic analysis in selecting antitumor therapy].
    Imianitov EN; Moiseenko VM
    Vopr Onkol; 2008; 54(2):121-32. PubMed ID: 18522159
    [No Abstract]   [Full Text] [Related]  

  • 9. Over-expression of clusterin is a resistance factor to the anti-cancer effect of histone deacetylase inhibitors.
    Liu T; Liu PY; Tee AE; Haber M; Norris MD; Gleave ME; Marshall GM
    Eur J Cancer; 2009 Jul; 45(10):1846-54. PubMed ID: 19342222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple effects of bioflavonoids on gene regulation, cell proliferation and apoptosis: natural compounds move into the lime light of cancer research.
    Strissel PL; Strick R
    Leuk Res; 2005 Aug; 29(8):859-61. PubMed ID: 15967500
    [No Abstract]   [Full Text] [Related]  

  • 11. CAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction is a major component of SHetA2-induced apoptosis in lung cancer cells.
    Lin YD; Chen S; Yue P; Zou W; Benbrook DM; Liu S; Le TC; Berlin KD; Khuri FR; Sun SY
    Cancer Res; 2008 Jul; 68(13):5335-44. PubMed ID: 18593935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional activation of the proapoptotic bik gene by E2F proteins in cancer cells.
    Real PJ; Sanz C; Gutierrez O; Pipaon C; Zubiaga AM; Fernandez-Luna JL
    FEBS Lett; 2006 Oct; 580(25):5905-9. PubMed ID: 17027756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New molecular mechanisms of action of camptothecin-type drugs.
    Legarza K; Yang LX
    Anticancer Res; 2006; 26(5A):3301-5. PubMed ID: 17094444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.
    Liu X; Yue P; Zhou Z; Khuri FR; Sun SY
    J Natl Cancer Inst; 2004 Dec; 96(23):1769-80. PubMed ID: 15572759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative and absolute configuration of versipelostatin, a down-regulator of molecular chaperone GRP78 expression.
    Park HR; Chijiwa S; Furihata K; Hayakawa Y; Shin-Ya K
    Org Lett; 2007 Apr; 9(8):1457-60. PubMed ID: 17352484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of gene expression of human tumor cells in testicular tumor].
    Niclas C; Sparwasser C
    Urologe A; 2007 Sep; 46(9):1185. PubMed ID: 17690861
    [No Abstract]   [Full Text] [Related]  

  • 17. Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumors.
    Tatsumi N; Oji Y; Tsuji N; Tsuda A; Higashio M; Aoyagi S; Fukuda I; Ito K; Nakamura J; Takashima S; Kitamura Y; Miyai S; Jomgeow T; Li Z; Shirakata T; Nishida S; Tsuboi A; Oka Y; Sugiyama H
    Int J Oncol; 2008 Mar; 32(3):701-11. PubMed ID: 18292948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in studies on inhibitor of apoptosis proteins and cancer therapy].
    Wang XH; Fu LW
    Yao Xue Xue Bao; 2006 Feb; 41(2):103-7. PubMed ID: 16671537
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of cancer cell survival by Par-4.
    Ranganathan P; Rangnekar VM
    Ann N Y Acad Sci; 2005 Nov; 1059():76-85. PubMed ID: 16382046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in RelA phosphorylation by inhibiting protein kinase A induces cell death in NF-kappaB-expressing and drug-resistant tumor cells.
    Manna SK; Gangadharan C
    Mol Immunol; 2009 Apr; 46(7):1340-50. PubMed ID: 19128834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.